PHARMA-PACK
InactiveNo longer registered with the KBO; last annual accounts for fiscal year 2022.
Signals
Two signals. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2022 was due by 31-07-2023 and was filed on 12-07-2023, 19 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2022
19 d early
2021
3 d late
2020
24 d late
2019
on the day
2018
on the day
2016
14 d early
2015
18 d late
← before the deadline
after the deadline →
Financials · fiscal year 2022, abbreviated schema
Equity
€1.72M▲ 61.0%
2021 · €1.07M
2019: €128k
2020: €557k
2021: €1.07M
2019 → 2022
Total assets
€2.91M▲ 34.8%
2021 · €2.16M
2019: €1.98M
2020: €2.35M
2021: €2.16M
2019 → 2022
Net result
€900k▲ 75.9%
2021 · €511k
2019: €-187k
2020: €429k
2021: €511k
2019 → 2022
Working capital
€1.67M▲ 113%
2021 · €784k
2019: €-159k
2020: €253k
2021: €784k
2019 → 2022
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2019202020212022Trend
Equity€128k-€557k▲ 335%€1.07M▲ 91.8%€1.72M▲ 61.0%
Operating result€-169k-€577k€726k▲ 25.7%€1.25M▲ 72.0%
Net result€-187k-€429k€511k▲ 19.2%€900k▲ 75.9%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen three years in a row; 2022 is 72% above 2021 and is the highest result in the available series.
Balance-sheet composition
2022 in colour, 2021 as the grey bar beneath
Assets €2.91M
Fixed assets
€48k▼ 88.4%
Current assets
€2.86M▲ 63.9%
Equity and liabilities €2.91M
Equity
€1.72M▲ 61.0%
Debt
€1.19M▲ 9.0%
The debt ratio falls from 50.5% to 40.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€1.29M▲
2021 · €762k
Cash flow
€939k▲
2021 · €548k
Solvency
59.1%▲
2021 · 49.5%
Current ratio
2.41▲
2021 · 1.81
Quick ratio
1.63▲
2021 · 0.93
Debt / equity
0.69▲
2021 · 0.12
ROE
52.3%▲
2021 · 47.9%
ROA
30.9%▲
2021 · 23.7%
Interest coverage
24.06
Debt
€1.19M▲
2021 · €1.09M
Debt ≤ 1 year
€1.19M▲
2021 · €962k
Income taxes
€344k▲
2021 · €194k
Staff costs
€1.88M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2022 against 2021
Balance sheet
Code20212022
Assets
Total assets20/58€2.16M€2.91M▲
Fixed assets21/28€412k€48k▼
Intangible fixed assets21€29k€26k▼
Tangible fixed assets22/27€381k€20k▼
Plant, machinery and equipment23-€12k
Furniture and vehicles24-€7k
Financial fixed assets28€2k€2k=
Current assets29/58€1.75M€2.86M▲
Stocks and contracts in progress3€855k€930k▲
Stocks30/36-€930k
Amounts receivable within one year40/41€643k€769k▲
Trade receivables40-€710k
Other amounts receivable41-€59k
Cash at bank and in hand54/58€248k€1.16M▲
Equity and liabilities
Total equity and liabilities10/49€2.16M€2.91M▲
Equity10/15€1.07M€1.72M▲
Contributions10/11-€15k
Reserves13€1.05M€1.71M▲
Non-distributable reserves130/1-€1k
Reserves not available under the articles1311-€1k
Tax-exempt reserves132-€6k
Distributable reserves133-€1.70M
Amounts payable17/49€1.09M€1.19M▲
Amounts payable after more than one year17€128k-
Amounts payable within one year42/48€962k€1.19M▲
Current portion of amounts payable after more than one year42-€12k
Trade debts44€308k€818k▲
Suppliers440/4-€818k
Taxes, remuneration and social security45-€356k
Taxes450/3-€250k
Remuneration and social security454/9-€106k
Other amounts payable47/48-€3k
Income statement
Code20212022
Remuneration, social security and pensions62-€1.88M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€37k€39k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€125k
Other operating charges640/8-€14k
Gross operating margin9900€1.89M€3.31M▲
Operating profit (loss)9901€726k€1.25M▲
Financial income75/76B-€53k
Recurring financial income75€7k€35k▲
Non-recurring financial income76B-€18k
Financial charges65/66B-€58k
Recurring financial charges65€29k€54k▲
Non-recurring financial charges66B-€5k
Profit (loss) for the period before taxes9903€706k€1.24M▲
Income taxes67/77€194k€344k▲
Profit (loss) for the period9904€511k€900k▲
Profit (loss) for the period to be appropriated9905€511k€900k▲
Appropriation of the result
Profit (loss) to be appropriated9906-€900k
Transfer to equity691/2-€900k
To other reserves6921-€900k
Social balance
Average headcount (FTE)9087-15.0
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2023
03-08
State Gazette act
General meeting · Merger
Name change · Power of attorney
12-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
03-05
State Gazette act
Board meeting · Merger
Power of attorney · Corporate purpose
2022
31-12
Financial
Highest result since 2019net €900k ▲75.9%
Operating result €1.25M, net result €900k, both a record.
2021
03-11
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 3 days late
31-03
Financial
Equity above €1MEq €1.07M ▲91.8%
2 profitable years in a row build equity to €1.07M.
2020
24-11
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
31-03
Financial
Back to profitnet €429k
Net result €429k after one loss-making year.
31-03
Financial
Equity above €500kEq €557k ▲335%
Equity rises from €128k to €557k.
2019
31-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
31-10
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
17-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
18-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 18 days late
2015
31-08
NBB filing
Annual accounts filed
fiscal year 2014 · abbreviated schema · 31 days late
2014
24-07
NBB filing
Annual accounts filed
fiscal year 2013 · abbreviated schema
2013
28-08
NBB filing
Annual accounts filed
fiscal year 2012 · abbreviated schema · 28 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Structure & network
Acquisitions and mergers
1 transactionTaken over by:INFINITY PHARMA